February 5, 2021
Omada CEO Sean Duffy and Chris Hogg, former COO at Propeller Health, join host Jonah Comstock to talk about virtual care, remote chronic condition management and just what healthcare will look like into the next decade.
Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Play!
What is virtual care?
Virtual care in a post-COVID telehealth landscape...
August 26, 2020
Digital respiratory health company Propeller Health is expanding its geographical footprint to Japan thanks to a partnership with pharma giant Novartis.
Patients living in Japan who take one of Novartis’ drugs to help with uncontrolled asthma, the Enerzair or Atectura Breezhaler, will be able to enroll in Propeller’s digital-management program.
Those that opt in can attach the Propeller’s...
July 7, 2020
Novartis and respiratory health company Propeller Health, a ResMed subsidiary, have teamed up to co-package the latter’s digital health platform with the pharma giant’s new asthma medication Enerzair Breezhaler.
This news come shortly after the product landed European Commission clearance. The co-packaged product will be launching in the EU during 2020. However, it is not yet available in the U....
June 25, 2020
Cancelled conference data trickles out. Digital respiratory-health company Propeller Health recently shared new study data that were accepted for presentation at the now cancelled Society of Behavioral Medicine 2020 Annual Meeting.
The first of the three abstracts described a sample of 617 adults with asthma or COPD, in which older patients engaged with Propeller's app for longer periods of time...
May 26, 2020
Digital respiratory health company Propeller Health has received 510(k) clearance for a sensor and app intended for use with AstraZeneca's Symbicort inhaler for asthma and COPD, the company announced today.
The tool – which, according to the agency, was submitted to the agency in September and greenlit in late March – was developed in a previously unannounced partnership with the Cambridge,...
May 4, 2020
Following numerous reports of underperforming COVID-19 antibody tests, the FDA has raised the bar for these products in a revision to its emergency testing policy.
As of today, commercial manufacturers that notify the agency of their intent to submit a test for Emergency Use Authorization are required to do so within 10 business days from the date of notification. Further, the FDA has recommended...
January 3, 2020
Stockholm-based respiratory health startup NuvoAir is set to make its technology available in selected cystic fibrosis (CF) centres after entering a new partnership with Roche Italy.
This marks NuvoAir’s first CF deal with a pharma company.
WHY IT MATTERS
According to the UK-based Cystic Fibrosis Trust, the genetic condition is estimated to affect around 100,000 people globally. It causes a...
December 12, 2019
About eight month after its unveiling, Express Scripts has now revealed the companies and programs it is including in the inaugural cohort of its digital health formulary — the first such resource from a pharmacy benefits manager designed to help clients review vetted digital health programs.
The formulary is comprised of 15 clinically validated digital health programs addressing the management...
November 20, 2019
Yesterday Propeller Health, maker of digital management tools for patients with respiratory conditions, announced a new deal with CVS, Walmart, Kroger, and Rite Aid, allowing its members to tap into the retail giants’ pharmacy services through the Propeller app.
Propeller is best known for its sensor-enabled inhalers, which can give patients and providers insights about use, symptom triggers and...
October 29, 2019
Alphabet serious about health wearables? Alphabet has reportedly put in an unspecified offer to buy out Fitbit, according to anonymous sources talking to Reuters. The news comes roughly a month after another report from the outlet suggesting that the wearables maker had brought on investment firm Qatalyst Partners to explore a potential sale, in which Alphabet was name dropped as a potential...